Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial Science Translational Medicine
Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration Journal of Controlled Release
Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration AIChE
